- Scheme Category:
- Other Scheme >
- Index Funds
NAV: ₹ 22.138 ↑ 1.28%
[as on 6 May, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth and its peers as on 6 May, 2026
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | - | - | - | - | - | 16.96% | -3.92% | 27.42% | 27.77% | 5.49% |
Discrete returns (monthly)
| Month | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 |
|---|
| Returns | 1.64% | 0.28% | -0.2% | 1.42% | 3.83% | -0.71% | -2.51% | 5.16% | -4.55% | 2.98% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 99.50% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
0.50% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 11.73% |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.59% |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 5.30% |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 5.08% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 4.84% |
| Dr. Reddy's Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 4.76% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.13% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 3.55% |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 2.77% |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 2.44% |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 2.37% |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 2.27% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 1.79% |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 1.72% |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.55% |
| IPCA Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 1.53% |
| Zydus Lifesciences Ltd. | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 1.23% |
| JB Chemicals & Pharmaceuticals Ltd. | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 1.19% |
| Aster DM Healthcare Ltd. | ASTERDM (INE914M01019) | Healthcare Services | 1.05% |
| Ajanta Pharma Ltd. | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 0.89% |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 0.87% |
| Narayana Hrudayalaya ltd. | NH (INE410P01011) | Healthcare Services | 0.82% |
| GlaxoSmithKline Pharmaceuticals Ltd. | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 0.70% |
| Global Health Ltd. | MEDANTA (INE474Q01031) | Healthcare Services | 0.55% |
| Emcure Pharmaceuticals Ltd. | EMCURE (INE168P01015) | Pharmaceuticals & Biotechnology | 0.31% |
| ELI LILLY & CO | US5324571083 | Pharmaceuticals | 5.72% |
| JOHNSON & JOHNSON | US4781601046 | Pharmaceuticals | 4.52% |
| ABBVIE INC | US00287Y1091 | Biotechnology | 2.95% |
| MERCK & CO.INC | US58933Y1055 | Pharmaceuticals | 2.29% |
| NOVARTIS AG | US66987V1098 | Pharmaceuticals | 2.23% |
| AMGEN INC | US0311621009 | Biotechnology | 1.45% |
| THERMO FISHER SCIENTIFIC INC | US8835561023 | Life Sciences Tools & Services | 1.41% |
| ABBOTT LABORATORIES | US0028241000 | Health Care Equipment & Supplies | 1.36% |
| GILEAD SCIENCES INC | US3755581036 | Biotechnology | 1.33% |
| INTUITIVE SURGICAL INC | US46120E6023 | Health Care Equipment & Supplies | 1.26% |
| DANAHER CORP | US2358511028 | Health Care Equipment & Supplies | 0.93% |
| Novo Nordisk A/S | US6701002056 | Pharmaceuticals & Biotechnology | 0.91% |
| STRYKER CORP | US8636671013 | Health Care Equipment & Supplies | 0.87% |
| VERTEX PHARMACEUTICALS INC | US92532F1003 | Biotechnology | 0.87% |
| MEDTRONIC PLC | IE00BTN1Y115 | Health Care Equipment & Supplies | 0.85% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | Pharmaceuticals | 0.63% |
| BECTON DICKINSON AND CO | US0758871091 | Health Care Equipment & Supplies | 0.34% |
| AGILENT TECHNOLOGIES INC | US00846U1016 | Life Sciences Tools & Services | 0.25% |
| IQVIA HOLDINGS INC | US46266C1053 | Life Sciences Tools & Services | 0.21% |
| WATERS CORP | US9418481035 | Pharmaceuticals | 0.09% |
Portfolio data is as on date 31 March, 2026
NAV history
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|
| 6 May, 2026 | 22.138 | 1.28% |
| 5 May, 2026 | 21.8592 | 0.43% |
| 4 May, 2026 | 21.7651 | 0.67% |
| 30 April, 2026 | 21.6209 | 0.83% |
| 29 April, 2026 | 21.4437 | -0.01% |
| 28 April, 2026 | 21.4462 | -0.01% |
| 27 April, 2026 | 21.4484 | 1.35% |
| 24 April, 2026 | 21.1632 | -1.3% |
| 23 April, 2026 | 21.4429 | 1.38% |
| 22 April, 2026 | 21.152 | 0.1% |
| 21 April, 2026 | 21.1315 | -0.26% |
| 20 April, 2026 | 21.1858 | -0.35% |
| 17 April, 2026 | 21.2593 | 0.55% |
| 16 April, 2026 | 21.1434 | -0.43% |
| 15 April, 2026 | 21.2339 | 1.25% |
| 13 April, 2026 | 20.9709 | 0.12% |
| 10 April, 2026 | 20.9461 | -0.27% |
| 9 April, 2026 | 21.0034 | 0.55% |
| 8 April, 2026 | 20.8877 | 0.94% |
| 7 April, 2026 | 20.6922 | 0.01% |
| 6 April, 2026 | 20.6897 | -0.04% |
| 2 April, 2026 | 20.6976 | -1.42% |
| 1 April, 2026 | 20.9957 | -0.43% |
| 31 March, 2026 | 21.0864 | 0.61% |
| 30 March, 2026 | 20.9592 | -0.87% |
| 27 March, 2026 | 21.1432 | -0.74% |
| 25 March, 2026 | 21.3008 | 1.79% |
| 24 March, 2026 | 20.9259 | 0.73% |
| 23 March, 2026 | 20.7737 | -1.18% |
| 20 March, 2026 | 21.0227 | |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The latest NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth is 22.138 as on 6 May, 2026.
What are YTD (year to date) returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The YTD (year to date) returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 3.29% as on 6 May, 2026.
What are 1 year returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The 1 year returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 14.78% as on 6 May, 2026.
What are 3 year CAGR returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The 3 year annualized returns (CAGR) of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 21.01% as on 6 May, 2026.
What are 5 year CAGR returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The 5 year annualized returns (CAGR) of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 13.12% as on 6 May, 2026.
